Limited Budget? Visit Healthcare Speakers Direct - our directory of SOH Approved speakers $5,000 and under. Preview and work directly with Business of Healthcare professionals $5,000 and under.

Healthcare Economist Keynote Speakers, Medical Speakers & Experts
Featured is a partial list of our Healthcare Economists. We invite you to contact us 503-345-9164 so that we may offer our Top Choices - based on your meeting goals, audience and budget.
Aaron Carroll, MD, MS
Aaron Carroll, MD, MS
Dr. Carroll is the Director of the Center for Health Policy and Professionalism Research and a Professor of Pediatrics at Indiana University School of Medicine and continues to be a sought after speaker on cost, quality and access -and the proposed healthcare legislation and its implications for our future. His blog: "The Incidental Economist" is one of the most widely read health policy blogs in the world and he is a regular contributor to the New York Times and the Huffington Post on health research and policy. His YouTube channel, "Healthcare Triage" received the 2015 National Institute of Health Care Management Digital Media Award.

Fee: Call For Quote

View More Information for Aaron Carroll, MD, MS
Stuart Altman
Stuart Altman
Dr. Stuart Altman, Sol C. Chaikin Professor of National Health Policy at The Heller School for Social Policy and Management, Brandeis University, is an economist with approximately five decades of experience working closely with issues of federal and state health policy within government, the private sector, and academia. He has served on numerous government advisory boards on both the federal and state levels and is recognized as a leader in the health care field. Modern Healthcare, Celebrating 30 Years, listed Stuart Altman among the 30 people who have had the most influence on healthcare over the past 30 years; and, for the past six years, they named him among the 100 Most Powerful People in Healthcare.

Fee: Call For Quote

View More Information for Stuart Altman
David Cutler
David Cutler
David Cutler, Harvard Professor of health economics and author of Your Money Or Your Life: Strong Medicine for America's Health Care System, was the subject of a feature article in the New York Times Magazine, by Roger Lowenstein titled: The Quality Cure. He served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration and was senior health care advisor to Barack Obama's Presidential campaign. Cutler was recently named one of the 30 people who could have a powerful impact on healthcare by Modern Healthcare magazine and one of the 50 most influential men aged 45 and younger by Details magazine.

Fee: Call For Quote

View More Information for David Cutler
Susan Dentzer
Susan Dentzer
Susan Dentzer, a leading national expert in health care and health policy, is the President and Chief Executive Officer of the Network for Excellence in Health Innovation. She also serves as the Senior health policy adviser for The Robert Wood Johnson Foundation (RWJF) and is past editor-in-chief of Health Affairs, the nation's leading journal of health policy. She also served as the on-air health correspondent for the PBS NewsHour from 1998 to 2008, and remains an on-air analyst on health policy for the show. A frequent guest on a number of National Public Radio programs, including This American Life and The Diane Rehm Show, she is a graduate of Dartmouth and holder of an honorary master of arts from the institution.

Fee: Call For Quote

View More Information for Susan Dentzer
John Goodman
John Goodman
John C. Goodman is president and CEO of the National Center for Policy Analysis, research fellow at the Independent Institute and author of the new Independent Institute book, Priceless: Curing the Healthcare Crisis. He is widely known as the "Father of Health Savings Accounts," and Modern Healthcare named him as one of four people who have most influenced the modern health care system.

Fee: Call For Quote

View More Information for John Goodman
Uwe Reinhardt, PhD
Uwe Reinhardt, PhD
Recognized as one of the nation's leading authorities on healthcare economics, Dr. Uwe Reinhardt has taught at Princeton University since 1968, where he is a James Madison Professor of Political Economy and Professor of Economics and Public Affairs at the Woodrow Wilson School of Public and International Affairs. A member of the Institute of Medicine of the National Academy of Sciences since 1978, Dr. Reinhard is a past president of the Association of Health Services Research and served as a commissioner on the Physician Payment Review Committee from 1986-1995. A frequent commentator in the media, Dr. Reinhardt offers enlightening and informative commentary on the economics of healthcare today.

Fee: Call For Quote

View More Information for Uwe Reinhardt, PhD
  • 61761844 - medicaid word cloud concept

    Medicaid is in the news every day. People, politicians, policymakers, providers, and payers are expressing points of view ranging from kill it to expand it. Unfortunately, most people are not well informed about what Medicaid is. I would like to help on the informing part of the issue by describing what it is, how it works, who qualifies, how much it costs, and some policy choices I see. This is a very complex subject, so I will lay it out in bite-sized posts. Consider this first post as a backgrounder. If you want to dig deep into the subject, I recommend visiting The Center on Budget and Policy Priorities.
    Read More ...

  • hospital

    Distress signals are starting to sound in two of the country’s major sectors, retail and healthcare. Last week, the discount shoe retailer Payless ShoeSource filed for Chapter 11 bankruptcy and announced it will close 400 brick-and-mortar stores throughout the United States and Puerto Rico. The announcement comes on the heels of a seemingly unending parade of bad news from traditional retailers in recent months. So far this year, Walmart, Macy’s, J.C. Penney among others, have all announced significant store closures. Ralph Lauren is shuttering its flagship Polo store, a foot-traffic magnet on tony Fifth Avenue in Manhattan, the latest step in a massive cost-cutting effort.
    Read More ...

  • magnifying-glass-1001506_640The payment landscape is shifting dramatically in the US health care industry and this has serious implications for the survival of providers. With the volume-to-value transformation, traditional fee-for-service payments are being replaced with a financial incentive framework that rewards for improved quality and outcomes. Although this impacts only Medicare payments today, it lays the groundwork and provides strong incentives for other payers to move in the same direction, thus potentially disrupting the health care system at all levels.

    Ultimately, value-based payments transform traditional business models by putting significant revenue– and risk– at stake. Building the outcomes-based financial models to maximize value-based care (VBC) reimbursement pathways will be fundamental to sustainable growth in the future.
    Read More ...

  • health-2082630_1280We are living through what is arguably the most challenging time for the health care industry. Globally, health care appears to be on a collision course with patient needs and economic reality. No one is happy with the current system, and the combination of rising costs, poor access, inequitable care, and diminishing quality and safety has created anxiety and frustration for all. Decades of interventions have failed to improve the situation; if anything, things have become worse. Current approaches tend to focus on a single issue or problem (the price of drugs, rising numbers without medical insurance, provider incentives to over treat), but an overarching solution has remained elusive.
    Read More ...

  • US Medical care illustrated by flag and stethoscope

    There is no issue more important to the future of America than it’s long-term fiscal sustainability. And the long-term fiscal sustainability of the United States has been placed in jeopardy primarily by the structure and expense of America’s healthcare system. According to the Congressional Budget Office, nearly the entirety of the growth in federal spending as a share of the economy—excluding interest—can be explained by government health programs: Medicare, Medicaid, the Medicaid-related Children’s Health Insurance Program, and the Affordable Care Act. In addition, one of the principal economic challenges faced by middle- and lower-income Americans is the expense and instability of American health insurance.
    Read More ...

  • Happy group of adult friends having fun

     3 Reasons Why Staying Social Matters to Your Thinking

    How many friends do you have? Do you rarely see family, go out for the evening or join your community for an event?

    You may not realize it, but your social life may just be bad for your brain.

    In the immortal words of Bette Midler, “you’ve got to have friends.” Little did the Divine Miss M know that in addition to our souls, she was hitting a high note on brain health as well.

    A recent AARP survey found that adults 40 and over with a higher number of social connections report better brain health.
    Read More ...

  • American Health Care Act

    After a seven year wait to repeal and replace President Barack Obama’s signature health care law, the GOP’s much-anticipated replacement collectively called the American Health Care Act (AHCA) was unveiled this week. Amidst a revolt from the left and right, doctors, hospitals and insurers, the plan cleared its first hurdle at 4.30 am on Thursday- approval by the House Ways and Means Committee and The House Energy and Commerce Committee after 18 and 27 of hours of debate respectively. It now has to be approved by a full House and the Senate…the former likely (although not guaranteed) and the latter impossible without bipartisan support.
    Read More ...

  • fixing the drug pricing problem

    The one thing that all Americans agree on – politicians included- is that prescription drug prices are on an unsustainable trajectory. Americans pay, by far, the highest prices for prescription drugs in the entire world. On average, Americans pay $1,100 per year for their drugs — $300 more than Germans or Canadians do. In addition, total US drug spending has more than doubled in the past 15 years, from $121.2 billion in 2000 up to nearly $374 billion in 2014, squeezing both payers and insurers alike……all of this while the largest pharmaceutical companies are cumulatively earning $80-$90 billion per year in profits at higher margins than other industries.
    Read More ...

Back To Top

info@SpeakersOnHealthcare.com   |   503-345-9164